(Q54204531)

26 May 2018

title

Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis. (English)

1 reference

26 May 2018

0 references

1 reference

Juan Carlos García-Pagan

1

1 reference

26 May 2018

author name string

F Feu

2

1 reference

26 May 2018

A Luca

3

1 reference

26 May 2018

M Fernández

4

1 reference

26 May 2018

P Pizcueta

5

1 reference

26 May 2018

J Bosch

6

1 reference

26 May 2018

J Rodés

7

1 reference

26 May 2018

publication date

1 June 1994

1 reference

26 May 2018

published in

Journal of Hepatology

1 reference

26 May 2018

volume

20

1 reference

26 May 2018

issue

6

1 reference

26 May 2018

page(s)

792-796

1 reference

26 May 2018

Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980151-5

7 January 2021

Chronic verapamil administration lowers portal pressure and improves hepatic function in rats with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980151-5

7 January 2021

The hemodynamic effect of verapamil on portal hypertension in patients with postnecrotic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980151-5

7 January 2021

Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980151-5

7 January 2021

Verapamil has no effect on porto-hepatic pressure gradient, hepatic blood flow and elimination function of the liver in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980151-5

7 January 2021

Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980151-5

7 January 2021

Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980151-5

7 January 2021

Hemodynamic evaluation of the patient with portal hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980151-5

7 January 2021

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980151-5

7 January 2021

Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980151-5

7 January 2021

10.1016/S0168-8278(05)80151-5

Identifiers

DOI

1 reference

26 May 2018

PubMed ID

7930480

1 reference

26 May 2018